Millennium Management LLC Acquires 5.2% Stake in Forte Biosciences, Inc. (FBRX)

On June 8, 2026, Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G disclosing a new 5.2% passive ownership stake in Forte Biosciences, Inc. (FBRX). The reporting persons collectively hold 1,062,182 shares of common stock, which were acquired for investment purposes rather than to influence or change the control of the issuer. The event triggering this filing occurred on June 4, 2026. The shares are held by various entities managed by Millennium Management LLC, with Millennium Group Management LLC serving as the managing member and Israel A. Englander as the sole voting trustee. The filing includes a joint filing agreement between the reporting parties, confirming their shared voting and dispositive power over the disclosed securities. This position represents a significant new holding for the investment firm in the clinical-stage biopharmaceutical company.